Torsten Eich1, Magnus Ståhle1, Bengt Gustafsson2, Rune Horneland3, Marko Lempinen4, Torbjörn Lundgren5, Ehab Rafael6, Gunnar Tufveson7, Bengt von Zur-Mühlen7, Johan Olerud1, Hanne Scholz3, Olle Korsgren1,8. 1. 1 Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. 2. 2 Department of Transplantation, Sahlgrenska University Hospital, Gothenburg, Sweden. 3. 3 Department of Transplantation, Oslo University Hospital, Rikshospitalet, Oslo, Norway. 4. 4 Department of Transplantation and Liver Surgery, Helsinki University Hospital, Helsinki, Finland. 5. 5 Division of Transplantation Surgery, CLINTEC, Karolinska University Hospital, Stockholm, Sweden. 6. 6 Transplantation Unit, Department of Surgery, Skåne University Hospital, Malmö, Sweden. 7. 7 Department of Surgical Sciences, Division of Transplantation Surgery, Uppsala University Hospital, Uppsala, Sweden. 8. 8 Department of Biomedicine, University of Gothenburg, Gothenburg, Sweden.
Abstract
BACKGROUND: Effective digestive enzymes are crucial for successful islet isolation. Supplemental proteases are essential because they synergize with collagenase for effective pancreatic digestion. The activity of these enzymes is critically dependent on the presence of Ca2+ ions at a concentration of 5-10 mM. The present study aimed to determine the Ca2+ concentration during human islet isolation and to ascertain whether the addition of supplementary Ca2+ is required to maintain an optimal Ca2+ concentration during the various phases of the islet isolation process. METHODS: Human islets were isolated according to standard methods and isolation parameters. Islet quality control and the number of isolations fulfilling standard transplantation criteria were evaluated. Ca2+ was determined by using standard clinical chemistry routines. Islet isolation was performed with or without addition of supplementary Ca2+ to reach a Ca2+ of 5 mM. RESULTS: Ca2+ concentration was markedly reduced in bicarbonate-based buffers, especially if additional bicarbonate was used to adjust the pH as recommended by the Clinical Islet Transplantation Consortium. A major reduction in Ca2+ concentration was also observed during pancreatic enzyme perfusion, digestion, and harvest. Additional Ca2+ supplementation of media used for dissolving the enzymes and during digestion, perfusion, and harvest was necessary in order to obtain the concentration recommended for optimal enzyme activity and efficient liberation of a large number of islets from the human pancreas. CONCLUSIONS: Ca2+ is to a large extent consumed during clinical islet isolation, and in the absence of supplementation, the concentration fell below that recommended for optimal enzyme activity. Ca2+ supplementation of the media used during human pancreas digestion is necessary to maintain the concentration recommended for optimal enzyme activity. Addition of Ca2+ to the enzyme blend has been implemented in the standard isolation protocols in the Nordic Network for Clinical Islet Transplantation.
BACKGROUND: Effective digestive enzymes are crucial for successful islet isolation. Supplemental proteases are essential because they synergize with collagenase for effective pancreatic digestion. The activity of these enzymes is critically dependent on the presence of Ca2+ ions at a concentration of 5-10 mM. The present study aimed to determine the Ca2+ concentration during human islet isolation and to ascertain whether the addition of supplementary Ca2+ is required to maintain an optimal Ca2+ concentration during the various phases of the islet isolation process. METHODS:Human islets were isolated according to standard methods and isolation parameters. Islet quality control and the number of isolations fulfilling standard transplantation criteria were evaluated. Ca2+ was determined by using standard clinical chemistry routines. Islet isolation was performed with or without addition of supplementary Ca2+ to reach a Ca2+ of 5 mM. RESULTS:Ca2+ concentration was markedly reduced in bicarbonate-based buffers, especially if additional bicarbonate was used to adjust the pH as recommended by the Clinical Islet Transplantation Consortium. A major reduction in Ca2+ concentration was also observed during pancreatic enzyme perfusion, digestion, and harvest. Additional Ca2+ supplementation of media used for dissolving the enzymes and during digestion, perfusion, and harvest was necessary in order to obtain the concentration recommended for optimal enzyme activity and efficient liberation of a large number of islets from the human pancreas. CONCLUSIONS:Ca2+ is to a large extent consumed during clinical islet isolation, and in the absence of supplementation, the concentration fell below that recommended for optimal enzyme activity. Ca2+ supplementation of the media used during human pancreas digestion is necessary to maintain the concentration recommended for optimal enzyme activity. Addition of Ca2+ to the enzyme blend has been implemented in the standard isolation protocols in the Nordic Network for Clinical Islet Transplantation.
Authors: Marika Bogdani; Eva Korpos; Charmaine J Simeonovic; Christopher R Parish; Lydia Sorokin; Thomas N Wight Journal: Curr Diab Rep Date: 2014-12 Impact factor: 4.810
Authors: J R Lakey; G L Warnock; R V Rajotte; M E Suarez-Alamazor; Z Ao; A M Shapiro; N M Kneteman Journal: Transplantation Date: 1996-04-15 Impact factor: 4.939
Authors: Andrew S Friberg; Torbjörn Lundgren; Helene Malm; Marie Felldin; Bo Nilsson; Trond Jenssen; Lauri Kyllönen; Gunnar Tufveson; Annika Tibell; Olle Korsgren Journal: Transplantation Date: 2012-03-27 Impact factor: 4.939
Authors: Bernhard J Hering; William R Clarke; Nancy D Bridges; Thomas L Eggerman; Rodolfo Alejandro; Melena D Bellin; Kathryn Chaloner; Christine W Czarniecki; Julia S Goldstein; Lawrence G Hunsicker; Dixon B Kaufman; Olle Korsgren; Christian P Larsen; Xunrong Luo; James F Markmann; Ali Naji; Jose Oberholzer; Andrew M Posselt; Michael R Rickels; Camillo Ricordi; Mark A Robien; Peter A Senior; A M James Shapiro; Peter G Stock; Nicole A Turgeon Journal: Diabetes Care Date: 2016-04-18 Impact factor: 19.112
Authors: H J Kissler; J C Niland; B Olack; C Ricordi; B J Hering; A Naji; F Kandeel; J Oberholzer; L Fernandez; J Contreras; T Stiller; J Sowinski; D B Kaufman Journal: Clin Transplant Date: 2009-08-30 Impact factor: 2.863
Authors: Magnus Ståhle; Aksel Foss; Bengt Gustafsson; Marko Lempinen; Torbjörn Lundgren; Ehab Rafael; Gunnar Tufveson; Olle Korsgren; Andrew Friberg Journal: Transplant Direct Date: 2015-06-24
Authors: Mototsugu Nagao; Jonathan L S Esguerra; Akira Asai; Jones K Ofori; Anna Edlund; Anna Wendt; Hitoshi Sugihara; Claes B Wollheim; Shinichi Oikawa; Lena Eliasson Journal: Diabetes Date: 2020-03-20 Impact factor: 9.461